Ocuphire Pharma Analyst Ratings
Ocuphire Pharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 373.93% | HC Wainwright & Co. | → $20 | Reiterates | Buy → Buy |
| 05/16/2023 | 373.93% | HC Wainwright & Co. | → $20 | Reiterates | Buy → Buy |
| 03/31/2023 | 373.93% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 02/17/2023 | 373.93% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 01/26/2023 | 373.93% | HC Wainwright & Co. | $26 → $20 | Maintains | Buy |
| 11/24/2021 | 516.11% | HC Wainwright & Co. | → $26 | Initiates Coverage On | → Buy |
| 04/05/2021 | 492.42% | Alliance Global Partners | → $25 | Initiates Coverage On | → Buy |
| 03/29/2021 | 373.93% | JonesTrading | → $20 | Initiates Coverage On | → Buy |
| 03/15/2021 | 373.93% | Cantor Fitzgerald | $15 → $20 | Maintains | Overweight |
| 02/10/2021 | 421.33% | Canaccord Genuity | → $22 | Initiates Coverage On | → Buy |
| 11/20/2020 | 255.45% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月14日 | 373.93% | HC Wainwright公司 | →$20 | 重申 | 購買→購買 |
| 2023年05月16日 | 373.93% | HC Wainwright公司 | →$20 | 重申 | 購買→購買 |
| 03/31/2023 | 373.93% | HC Wainwright公司 | →$20 | 重申 | →購買 |
| 02/17/2023 | 373.93% | HC Wainwright公司 | →$20 | 重申 | →購買 |
| 2023年1月26日 | 373.93% | HC Wainwright公司 | $26→$20 | 維護 | 買 |
| 2021年11月24日 | 516.11% | HC Wainwright公司 | →$26 | 開始承保 | →購買 |
| 04/05/2021 | 492.42% | 聯盟全球合作夥伴 | →$25 | 開始承保 | →購買 |
| 03/29/2021 | 373.93% | Jones Trading | →$20 | 開始承保 | →購買 |
| 03/15/2021 | 373.93% | 康託·菲茨傑拉德 | $15→$20 | 維護 | 超重 |
| 02/10/2021 | 421.33% | 卡納科特·格納奇 | →$22 | 開始承保 | →購買 |
| 11/20/2020 | 255.45% | 康託·菲茨傑拉德 | →$15 | 開始承保 | →超重 |
What is the target price for Ocuphire Pharma (OCUP)?
Ocuphire Pharma(OCUP)的目標價是多少？
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $20.00 expecting OCUP to rise to within 12 months (a possible 373.93% upside). 5 analyst firms have reported ratings in the last year.
奧克菲爾製藥公司(納斯達克代碼：OCUP)的最新目標價是由HC Wainwright&Co.於2023年8月14日報道的。這家分析公司將目標價定為20美元，預計股票價格將在12個月內上漲(可能上漲373.93)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Ocuphire Pharma (OCUP)?
Ocuphire Pharma(OCUP)的最新分析師評級是多少？
The latest analyst rating for Ocuphire Pharma (NASDAQ: OCUP) was provided by HC Wainwright & Co., and Ocuphire Pharma reiterated their buy rating.
Ocuphire Pharma(納斯達克代碼：OCUP)的最新分析師評級由HC Wainwright&Co.提供，Ocuphire Pharma重申其買入評級。
When is the next analyst rating going to be posted or updated for Ocuphire Pharma (OCUP)?
Ocuphire Pharma(OCUP)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocuphire Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocuphire Pharma was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Ocuphire Pharma的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Ocuphire Pharma的上一次評級是在2023年8月14日提交的，所以你應該預計下一次評級將在2024年8月14日左右的某個時候公佈。
Is the Analyst Rating Ocuphire Pharma (OCUP) correct?
分析師對Ocuphire Pharma(OCUP)的評級正確嗎？
While ratings are subjective and will change, the latest Ocuphire Pharma (OCUP) rating was a reiterated with a price target of $0.00 to $20.00. The current price Ocuphire Pharma (OCUP) is trading at is $4.22, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Ocuphire Pharma(OCUP)評級被重申，目標價在0.00美元至20.00美元之間。Ocuphire Pharma(OCUP)目前的交易價格為4.22美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。